CCCC
C4 Therapeutics Inc
3.00$
-6.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 67.2% | 72.0% | 70.2% | 72.4% | 72.7% | 73.7% | 72.8% | 75.8% | 77.9% | 71.9% | 74.6% | 73.1% | |
| 18.3% | 33.6% | 22.5% | 19.2% | 15.9% | 15.9% | 16.1% | 26.4% | 22.2% | 20.8% | 18.6% | 21.9% | |
| 65.0% | 67.4% | 64.8% | 69.3% | 68.0% | 70.1% | 67.3% | 72.4% | 72.3% | 69.2% | 71.7% | 70.6% | |
| 0.2% | 3.1% | 3.4% | 0.3% | 2.7% | 0.9% | 2.5% | 0.7% | 2.5% | 0.7% | 0.9% | 0.4% | |
| 0.0% | – | – | 0.0% | – | – | – | – | – | – | – | – | |
| 35.1% | 34.6% | 35.2% | 35.2% | 35.5% | 38.2% | 38.9% | 41.3% | 41.8% | 28.5% | 28.8% | 31.2% | |
| 9.1% | 11.4% | 13.8% | 14.2% | 11.5% | 12.9% | 12.8% | 15.0% | 13.5% | 9.2% | 8.3% | 13.4% | |
| 1.5% | 1.4% | 1.3% | 1.4% | 1.5% | 1.7% | 1.9% | 2.0% | 2.3% | 1.8% | 2.0% | 1.9% | |
| 0.4% | 0.4% | 0.4% | 0.2% | 0.4% | 0.4% | 0.2% | 0.7% | 0.5% | 0.2% | 0.2% | 0.3% | |
| 64.9% | 65.4% | 64.8% | 64.8% | 64.5% | 61.8% | 61.1% | 58.7% | 58.2% | 71.5% | 71.2% | 68.8% | |
| -148.2% | -140.4% | -139.8% | -150.7% | -159.3% | -181.3% | -206.6% | -231.4% | -270.5% | -205.7% | -232.3% | -219.1% | |
| 14.8% | 13.6% | 17.2% | 18.1% | 18.5% | 20.2% | 22.2% | 23.9% | 27.3% | 32.5% | 38.3% | 36.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.